Skip Navigation


Human Molecular Genetics Advance Access originally published online on October 7, 2004
Human Molecular Genetics 2004 13(23):2947-2957; doi:10.1093/hmg/ddh320
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/23/2947    most recent
ddh320v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cossins, J.
Right arrow Articles by Beeson, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cossins, J.
Right arrow Articles by Beeson, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol. 13, No. 23 © Oxford University Press 2004; all rights reserved

A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition

Judy Cossins, Richard Webster, Susan Maxwell, Georgina Burke, Angela Vincent and David Beeson*

Neurosciences Group, Weatherall Institute of Molecular Medicine, The John Radcliffe, Oxford OX3 9DS, UK

Received July 30, 2004; Accepted September 26, 2004

The two subtypes of mammalian muscle nicotinic acetylcholine receptors (AChR) are generated by the substitution of the {varepsilon} (adult) subunit for the {gamma} (fetal) subunit within the AChR pentamer. Null mutations of the adult AChR {varepsilon}-subunit gene are the most common cause of the AChR deficiency syndrome. This is a disorder of neuromuscular transmission characterized by non-progressive fatigable muscle weakness present throughout life. In contrast with the human disorder, mice with AChR {varepsilon}-subunit null mutations die between 10 and 14 weeks of age. We generated transgenic mice that constitutively express the human AChR {gamma}-subunit in an AChR {varepsilon}-subunit ‘knock-out’ background. These mice, in which neuromuscular transmission is mediated by fetal AChR, live well into adult life but show striking similarities to human AChR deficiency syndrome. They display fatigable muscle weakness, reduced miniature endplate potentials and endplate potentials, reduced motor endplate AChR number and altered endplate morphology. Our results illustrate how species differences in the control of ion-channel gene expression may affect disease phenotype, demonstrate that expression of adult AChR subtype is not essential for long-term survival, and suggest that in patients with AChR deficiency syndrome, up-regulation of the {gamma}-subunit could be a beneficial therapeutic strategy.

* To whom correspondence should be addressed. Email: dbeeson{at}hammer.imm.ox.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
Y. Liu, D. Padgett, M. Takahashi, H. Li, A. Sayeed, R. W. Teichert, B. M. Olivera, J. J. McArdle, W. N. Green, and W. Lin
Essential roles of the acetylcholine receptor {gamma}-subunit in neuromuscular synaptic patterning
Development, June 1, 2008; 135(11): 1957 - 1967.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Escher, E. Lacazette, M. Courtet, A. Blindenbacher, L. Landmann, G. Bezakova, K. C. Lloyd, U. Mueller, and H. R. Brenner
Synapses Form in Skeletal Muscles Lacking Neuregulin Receptors
Science, June 24, 2005; 308(5730): 1920 - 1923.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.